Autor: |
Neuzil, Petr, Merkely, Béla, Erglis, Andrejs, Marinskis, Germanas, de Groot, Joris R, Schmidinger, Herwig, Rodriguez Venegas, Manuel, Voskuil, Michiel, Sturmberger, Thomas, Petru, Jan, Jongejan, Niels, Aichinger, Josef, Kamzola, Ginta, Aidietis, Audrius, Gellér, Laszlo, Mraz, Tomas, Osztheimer, Istvan, Mika, Yuval, Evans, Steven, Burkhoff, Daniel, Kuck, Karl Heinz, BackBeat Study Investigators |
Jazyk: |
angličtina |
Rok vydání: |
2017 |
Předmět: |
|
Popis: |
BACKGROUND: Many patients requiring a pacemaker have persistent hypertension with systolic blood pressures above recommended levels. We evaluated a pacemaker-based Programmable Hypertension Control (PHC) therapy that uses a sequence of variably timed shorter and longer atrioventricular intervals. METHODS AND RESULTS: Patients indicated for dual-chamber pacing with office systolic blood pressure (oSBP) >150 mm Hg despite stable medical therapy were implanted with a Moderato™ pulse generator that delivers PHC therapy. Patients were followed for 1 month (Run-In period) with conventional pacing; those with persistent oSBP >140 mm Hg were included in the study and had PHC therapy activated. The co-primary efficacy end points were changes in 24-hour ambulatory systolic blood pressure and oSBP between baseline and 3 months. Safety was assessed by tracking adverse events. Thirty-five patients met the initial inclusion criteria and underwent Moderato implantation. At 1 month, oSBP was |
Databáze: |
OpenAIRE |
Externí odkaz: |
|